Bazooka Joe
22p6 comments posted · 0 followers · following 0
10 years ago @ Clinical Leader - CRO,... - Is Preventing Dual Enr... · 0 replies · +1 points
In some countries, such as the UK with its universal healthcare system, a mechanism already exists that could be used, namely the NHS number. However in the process described, given the information is de-identified I can only see this being of very limited use. It may even give a sense of false security to the researcher. Now, if unique IDs such as SSNs were used I could see it actually working although this would have to be weighed against the likelihood of potential subjects not wanting to share their SSNs when it is not to their benefit.
10 years ago @ Clinical Leader - CRO,... - High Drug Prices Shoul... · 0 replies · +3 points
Pharma will still be profitable, but maybe not AS profitable. That's the point I was making.
10 years ago @ Clinical Leader - CRO,... - High Drug Prices Shoul... · 0 replies · +3 points
This is a hackneyed mantra that Pharma loves to chant, despite no independent substantiated verification, much like the NRA chants that "guns don't kill..."
Also your phrase, "It has been estimated that only one in 5,000 compounds that undergo preclinical testing gets approval." may well be true, but is a little disingenuous as relatively little cost is incurred per compound at the HTS stage. By the time an IMP has made it to phase III development, when costs do really start to soar, the failure rate is probably closer to 1 in 5, in my experience, assuming a half-decent R&D team at the helm who know when to kill a poor product.
So, in short, it will be a long, long time before we see the new Mercedes, BMWs and Porsches replaced with 10-year old Fords and Kia's in the Pharma parking lots.
14 years ago @ Deep Thoughts - Is Bachmann lying? · 0 replies · +2 points
14 years ago @ Atheist Revolution - Too Weak To Be An Athe... · 0 replies · +2 points
14 years ago @ Atheist Revolution - Too Weak To Be An Athe... · 2 replies · +2 points